Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
Gary M. Clifford(Centre international de recherche sur le cancer), Silvia Franceschi(Centre international de recherche sur le cancer), Olivia Keiser(University of Bern), Gernot Jundt(Swiss Cancer Center Léman), Luigino Dal Maso(Media Working Group), T. Fisch(Swiss Cancer Center Léman), Elisabetta Rapiti(Hospital Neuchâtel), Jerry Polesel(Centro di Riferimento Oncologico), Andrea Bordoni(Swiss Cancer Center Léman), D. de Weck(Swiss Cancer Center Léman), Fabio Levi, Martin Rickenbach(Swiss Data Science Center), Andreas Kofler(University of Zurich)
Cited by 857
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
|British Journal of Cancer|2003|1.6k